The Ukraine has been a hot topic in the news due to the recent turmoil in the country. Even during these difficult times, drug development and clinical trials continue to be run in the Ukraine, which boasts recruitment figures at least two times higher than those in the United States and Western Europe. To view a recording of this webinar, click here
HOUSTON, TEXAS - November 4th, 2014. Pharm-Olam International Ltd., a multi-national, full-service CRO to biopharmaceutical and device industries is proud to celebrate 20 years of successfully helping our sponsors create a healthier world.
As a thank you for subscribing, you'll receive a free copy of our GDPR Controller & Processor Checklist
Pharm-Olam was contracted to provide a full-service solution for two Phase II, dose escalation allergy studies that required a total of 500 patients in Europe. With two different allergy indications, Grass Pollen and Birch Pollen, these studies presented some unique challenges.
In our continued quest to reduce time and effort to bring medicines to market; Pharm-Olam is pleased to announce expansion into Israel. Pharm-Olam continues to look to increase its strategic footprint to offer our clients a greater choice to support their clinical trials. Incorporating Israel into your clinical trials offers you several benefits including:
HOUSTON, TX – Pharm-Olam International Ltd. a multi-national, full service provider of outsourced development services to the pharmaceutical and biotech industries, announced its successful expansion of clinical trial services into Kazakhstan.